# Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-07-22

Status: RECRUITING · Sponsor: BioNTech SE · Condition: Non-Small Cell Lung Cancer

- Company: BioNTech SE
- Sector: Non-Small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT05142189

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.